{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:05:36Z","timestamp":1785186336461,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017639","name":"Entasis Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017639","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jchromb.2025.124654","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:03:34Z","timestamp":1747220614000},"page":"124654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Quantification of sulbactam and durlobactam in saline and human plasma via ultra-performance liquid chromatography tandem mass spectrometry"],"prefix":"10.1016","volume":"1261","author":[{"given":"Hanna F.","family":"Roenfanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Kuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124654_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.709974","article-title":"Durlobactam, a new Diazabicyclooctane \u03b2-lactamase inhibitor for the treatment of Acinetobacter infections in combination with Sulbactam","volume":"12","author":"Shapiro","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jchromb.2025.124654_bb0010","series-title":"2526. Ex Vivo Assessment of Sulbactam-Durlobactam (SUL-DUR) Clearance during Continuous Renal Replacement Therapy (CRRT), Open Forum Infectious Diseases, 10","author":"Abouelhassan","year":"2023"},{"key":"10.1016\/j.jchromb.2025.124654_bb0015","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/cid\/ciad095","article-title":"Durlobactam, a broad-Spectrum serine \u03b2-lactamase inhibitor, restores Sulbactam activity against Acinetobacter species","volume":"76","author":"Papp-Wallace","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2025.124654_bb0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40265-023-01920-6","article-title":"Sulbactam\/durlobactam: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2025.124654_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01506-19","article-title":"Pharmacokinetics and tolerability of intravenous Sulbactam-Durlobactam with imipenem-Cilastatin in hospitalized adults with complicated urinary tract infections, including acute pyelonephritis","volume":"64","author":"Sagan","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124654_bb0030","article-title":"Plasma and intrapulmonary concentrations of ETX2514 and Sulbactam following intravenous administration of ETX2514SUL to healthy adult subjects","volume":"62","author":"Rodvold","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124654_bb0035","article-title":"In vivo dose response and efficacy of the \u03b2-lactamase inhibitor, durlobactam, in combination with sulbactam against the Acinetobacter baumannii-calcoaceticus complex","volume":"68","author":"O\u2019Donnell","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124654_bb0040","series-title":"M10 Bioanalytrical Method Validation and Study Sample Analysis: Guidance for Industry","author":"Food and Drug Administration Center for Drug Evaluation and Research","year":"2022"},{"key":"10.1016\/j.jchromb.2025.124654_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00071-20","article-title":"Safety, pharmacokinetics, and drug-drug interaction potential of intravenous Durlobactam, a \u03b2-lactamase inhibitor, in healthy subjects","volume":"64","author":"Lickliter","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124654_bb0050","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/cts.12991","article-title":"A randomized, double-blind, placebo- and positive-controlled crossover study of the effects of durlobactam on cardiac repolarization in healthy subjects","volume":"14","author":"O\u2019Donnell","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jchromb.2025.124654_bb0055","first-page":"e00312","article-title":"In vitro pharmacokinetics\/pharmacodynamics of the \u03b2-lactamase inhibitor, durlobactam, in combination with sulbactam against Acinetobacter baumannii-calcoaceticus complex","volume":"68","author":"O\u2019Donnell","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124654_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01674-23","article-title":"Ex vivo assessment of sulbactam-durlobactam clearance during continuous renal replacement therapy to guide dosing recommendations","volume":"69","author":"Abouelhassan","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124654_bb0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/rcm.1790","article-title":"Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography\/mass spectrometry: necessity or not?","volume":"19","author":"Stokvis","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2025.124654_bb0070","author":"Kufel","year":"2024"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:11:50Z","timestamp":1762553510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":14,"alternative-id":["S1570023225002089"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124654","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of sulbactam and durlobactam in saline and human plasma via ultra-performance liquid chromatography tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124654"}}